Skip to search formSkip to main contentSkip to account menu

CS 706

Known as: TG01, CS706 cpd, TP2001 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The edible medicinal mushroom Flammulina velutipes (enokitake) has many applications as food and medicine, but its application in… 
2017
2017
4119Background: TG01 (a mixture of 7 RAS peptides) is an injectable antigen-specific cancer immunotherapy targeted to treat… 
2009
2009
The occurrence of Heterorhabditis brevicaudis (Rhabditida: Heterorhabditidae) and its symbiotic bacteria, Photorhabdusluminescens… 
2009
2009
  • P. RaoR. Grover
  • 2009
  • Corpus ID: 9084571
Apricoxib (CS-706), a small-molecule, orally active, selective COX-2 inhibitor, is under development by Tragara Pharmaceuticals… 
2008
2008
AIM To develop a pain relief model for a cyclooxygenase (COX)-2 inhibitor, CS-706, that permits prediction of doses for acute… 
2007
2007
Biliary tract cancer is still challenging to treat and manage due to its poor sensitivity to conventional therapies and the… 
2007
2007
In rats, it has been reported that rofecoxib, a cyclooxygenase-2 (COX-2) inhibitor, reacts with the aldehyde group of allysine in… 
2007
2007
CS-706 is a novel cyclooxygenase-2 (COX-2) inhibitor with potent analgesic, anti-inflammatory, and antitumor properties in animal… 
1988
1988
Elliptinium acetate (EA) is a new anti‐cancer compound displaying cytostatic activity against various malignancies including…